אגרסטט

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

TIROFIBAN AS HYDROCHLORIDE MONOHYDRATE 0.25 MG/ML

Mevcut itibaren:

TZAMAL BIO-PHARMA LTD

ATC kodu:

B01AC17

Farmasötik formu:

SOLUTION FOR INFUSION

Uygulama yolu:

I.V

Tarafından üretildi:

MERCK SHARP & DOHME B.V, HOLLAND

Terapötik grubu:

TIROFIBAN

Terapötik endikasyonlar:

Aggrastat in combination with heparin, is indicated for patients with unstable angina or non-Q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy. In this setting, AGGRASTAT has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

Yetkilendirme tarihi:

2009-09-01